Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Prospective, Historic-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Infusion of Liver Cell Suspension (HHLivC) in Children With Urea Cycle Disorders.

NCT01195753 is registered in ClinicalTrials.gov with Cytonet GmbH & Co. KG as lead sponsor.

NCT NCT01195753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01195753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Prospective, Historic-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Infusion of Liver Cell Suspension (HHLivC) in Children With Urea Cycle Disorders.
Lead sponsor
Cytonet GmbH & Co. KG
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2010
Completion date
December 31, 2015
Enrollment
10 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

urea cycle disorders